192 related articles for article (PubMed ID: 29175363)
1. Bone morphogenetic protein signaling through ACVR1 and BMPR1A negatively regulates bone mass along with alterations in bone composition.
Shi C; Mandair GS; Zhang H; Vanrenterghem GG; Ridella R; Takahashi A; Zhang Y; Kohn DH; Morris MD; Mishina Y; Sun H
J Struct Biol; 2018 Mar; 201(3):237-246. PubMed ID: 29175363
[TBL] [Abstract][Full Text] [Related]
2. Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.
Zhang Y; McNerny EG; Terajima M; Raghavan M; Romanowicz G; Zhang Z; Zhang H; Kamiya N; Tantillo M; Zhu P; Scott GJ; Ray MK; Lynch M; Ma PX; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2016 Jul; 88():74-84. PubMed ID: 27113526
[TBL] [Abstract][Full Text] [Related]
3. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
5. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
[TBL] [Abstract][Full Text] [Related]
6. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
[TBL] [Abstract][Full Text] [Related]
7. Mechanical Loading Synergistically Increases Trabecular Bone Volume and Improves Mechanical Properties in the Mouse when BMP Signaling Is Specifically Ablated in Osteoblasts.
Iura A; McNerny EG; Zhang Y; Kamiya N; Tantillo M; Lynch M; Kohn DH; Mishina Y
PLoS One; 2015; 10(10):e0141345. PubMed ID: 26489086
[TBL] [Abstract][Full Text] [Related]
8. AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: implications for myocardial differentiation and regional identity.
Thomas PS; Rajderkar S; Lane J; Mishina Y; Kaartinen V
Dev Biol; 2014 Jun; 390(2):191-207. PubMed ID: 24680892
[TBL] [Abstract][Full Text] [Related]
9. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
[TBL] [Abstract][Full Text] [Related]
10. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
11. ACVR1 is essential for periodontium development and promotes alveolar bone formation.
Zhang X; Liu Q; Zhao H; Hu Y; Liu C; Yan G; Li D; Mishina Y; Shi C; Sun H
Arch Oral Biol; 2018 Nov; 95():108-117. PubMed ID: 30098439
[TBL] [Abstract][Full Text] [Related]
12. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
[TBL] [Abstract][Full Text] [Related]
13. Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse.
Lim J; Shi Y; Karner CM; Lee SY; Lee WC; He G; Long F
Development; 2016 Jan; 143(2):339-47. PubMed ID: 26657771
[TBL] [Abstract][Full Text] [Related]
14. Disruption of bone morphogenetic protein type IA receptor in osteoblasts impairs bone quality and bone strength in mice.
Bao Q; Li A; Chen S; Feng J; Liu H; Qin H; Li J; Liu D; Shen Y; Zong Z
Cell Tissue Res; 2018 Nov; 374(2):263-273. PubMed ID: 29987355
[TBL] [Abstract][Full Text] [Related]
15. BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.
Shi C; Zhang H; Louie K; Mishina Y; Sun H
J Cell Biochem; 2017 Mar; 118(3):605-614. PubMed ID: 27649478
[TBL] [Abstract][Full Text] [Related]
16. Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.
Zhang H; Zhang Y; Terajima M; Romanowicz G; Liu Y; Omi M; Bigelow E; Joiner DM; Waldorff EI; Zhu P; Raghavan M; Lynch M; Kamiya N; Zhang R; Jepsen KJ; Goldstein S; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2020 Aug; 137():115402. PubMed ID: 32360900
[TBL] [Abstract][Full Text] [Related]
17. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1
Wentworth KL; Lalonde RL; Groppe JC; Brewer N; Moody T; Hansberry S; Taylor KE; Shore EM; Kaplan FS; Pignolo RJ; Yelick PC; Hsiao EC
J Bone Miner Res; 2022 Nov; 37(11):2058-2076. PubMed ID: 36153796
[TBL] [Abstract][Full Text] [Related]
18. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC
Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160
[TBL] [Abstract][Full Text] [Related]
19. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
Omi M; Kaartinen V; Mishina Y
J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
[TBL] [Abstract][Full Text] [Related]
20. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
